Refreshed just now
https://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-inflation-rebate-program
Why it’s here: This CMS page is a federal rulemaking and implementation hub for the Medicare Prescription Drug Inflation Rebate Program, which touches biotech drug-pricing policy affecting innovation, but it is a navigation/archive page of guidance and forms rather than a substantive policy development.
Trace across the boardItem
5d agoCenters for Medicare & Medicaid Services (CMS) · research by Centers for Medicare & Medicaid Serviceshttps://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-inflation-rebate-programCMS posted an updated Medicare Prescription Drug Inflation Rebate Program page covering CY2027 final rulemaking, the 340B repository help desk, information collection requests, and manufacturer portal resources.1 outlet7 linked
Connected
6 links- Newshttps://www.cms.gov/initiatives/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/regulations-guidance-policy-documentsBoth involve Inflation Reduction Act, Centers for Medicare & Medicaid Services
- NewsCMS postpones RPM payment halt for 2 yearsBoth involve Centers for Medicare & Medicaid Services
- NewsMedicare’s AI-assisted coverage review pilot hit early snags, documents showBoth involve Centers for Medicare & Medicaid Services
- Newshttps://www.cms.gov/initiatives/health-technology-ecosystem/overview/clinical-si-roadmapBoth involve Centers for Medicare & Medicaid Services
- MoneyEPATHUSA, INC. — Centers for Medicare and Medicaid Services award 75FCMC26C0007Both involve Centers for Medicare & Medicaid Services
- NewsTrump administration releases roadmap to boost clinical AIBoth involve Centers for Medicare & Medicaid Services
About
- Inflation Reduction Act
- Centers for Medicare & Medicaid Services
- Bureau of Labor Statistics